Targeting HDAC2 with bruceine D epigenetically restores SMAD3 expression via H4K16ac enrichment to suppress malignant progression in EGFR-TKI-resistant lung adenocarcinoma.
- DOI
- 10.1016/j.jep.2026.122109
- Published
- 2026 Dec 6
- Container
- Journal of ethnopharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jep.2026.122109,
title = {Targeting HDAC2 with bruceine D epigenetically restores SMAD3 expression via H4K16ac enrichment to suppress malignant progression in EGFR-TKI-resistant lung adenocarcinoma.},
author = {Wang K and Wu Z and Lu B and Tao X and Chen P and Lu T and Gao M and Zhang H and Song Y and Ke X},
year = {2026},
journal = {Journal of ethnopharmacology},
doi = {10.1016/j.jep.2026.122109},
url = {https://doi.org/10.1016/j.jep.2026.122109}
}RIS
TY - JOUR TI - Targeting HDAC2 with bruceine D epigenetically restores SMAD3 expression via H4K16ac enrichment to suppress malignant progression in EGFR-TKI-resistant lung adenocarcinoma. AU - Wang K AU - Wu Z AU - Lu B AU - Tao X AU - Chen P AU - Lu T AU - Gao M AU - Zhang H AU - Song Y AU - Ke X PY - 2026 JO - Journal of ethnopharmacology DO - 10.1016/j.jep.2026.122109 UR - https://doi.org/10.1016/j.jep.2026.122109 ER -
APA
K, W., Z, W., B, L., X, T., P, C., T, L., M, G., H, Z., Y, S., & X, K. (2026). Targeting HDAC2 with bruceine D epigenetically restores SMAD3 expression via H4K16ac enrichment to suppress malignant progression in EGFR-TKI-resistant lung adenocarcinoma.. Journal of ethnopharmacology. https://doi.org/10.1016/j.jep.2026.122109
Source records
- pubmed · retrieved 2026-09-26T04:19:55.679Z